Tarsus Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC TARS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

66,335

Value ($000)

5,432

Weight

0.0%

2024 Q1 - 2025 Q4 (8 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	5,432	0.0%	66,335	12/31/2025
2025 Q3	11/14/2025	3,720	0.0%	62,603	9/30/2025
2025 Q2	8/14/2025	3,499	0.0%	86,378	6/30/2025
2025 Q1	5/19/2025	3,659	0.0%	71,220	3/31/2025
2024 Q4	2/14/2025	3,866	0.0%	69,826	12/31/2024
2024 Q3	11/14/2024	1,935	0.0%	58,835	9/30/2024
2024 Q2	8/14/2024	1,444	0.0%	53,126	6/30/2024
2024 Q1	5/15/2024	826	0.0%	22,720	3/31/2024